Immune status at presentation to care did not improve among antiretroviral-naive persons from 1990 to 2006

Clinical Infectious Diseases

Volumn 45, Issue 10, 2007, Pages 1369-1374

  Keruly, Jeanne C ^a   Moore, Richard D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ELDERLY CARE; ETHNICITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT CARE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; VIRUS TRANSMISSION; AGE; IMMUNOLOGY; MIDDLE AGED; RACE; RISK FACTOR; SEX DIFFERENCE; TIME; UNITED STATES;

ADULT; AGE FACTORS; CD4 LYMPHOCYTE COUNT; CONTINENTAL POPULATION GROUPS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MARYLAND; MIDDLE AGED; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 36048977066     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/522759     Document Type: Article

References (27)

1. HIV/AIDS Bureau, Health Resources and Services Administration, US Department of Health and Human Services. The Ryan White AIDS Program. Available at: http://hab.hrsa.gov/history.htm. Accessed 4 October 2007.
2. HIV/AIDS Bureau, Health Resources and Services Administration, US Department of Health and Human Services. Available at: http://www.nmac.org/ nmac2/PDF/NMAPP_RyanWhite_Paper.pdf. Accessed 4 October 2007.
3. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. MMWR Recomm Rep 2001; 50:1-62.
4. Glynn M, Rhodes P. Estimated HIV prevalence in the United States at the end of 2003 [abstract T1-B1101]. In: Proceedings of the National HIV Prevention Conference (Atlanta). Atlanta: Centers for Disease Control and Prevention, 2005.
5. Palella FJ, Delana KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338:853-60.
6. Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 1998; 352:1725-30.
7. Moore RD, Chaisson RE. Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS 1999; 13:1933-42.
8. McNaghten AD, Hanson DL, Jones JL, et al. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after and AIDS diagnosis: Adult/Adolescent Spectrum of Disease group. AIDS 1999; 13:1687-95.
9. Kaplan JE, Hanson D, Dworkin MS, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 30(Suppl 1):S5-14.
10. Centers for Disease Control and Prevention. Late versus early testing of HIV - 16 sites, United States, 2000-2003. MMWR Morb Mortal Wkly Rep 2003; 52:181-6.
11. Moore RD. Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV Clinical Practice Cohort. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17(Suppl 1):S38-41.
12. Margolick JB, Munoz A, Vlahov D, et al. Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users. Arch Intern Med 1994; 154:869-75.
13. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41.
14. Krawczyk CS, Funkhouser, E, Kilby JM, et al. Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic. South Med J 2006; 99:472-81.
15. Paltiel AD, Walensky RP, Schackman BR, et al. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Ann Intern Med 2006; 145:797-806.
16. Centers for Disease Control and Prevention. HIV/AIDS surveillance report, 2005. Vol 16. Atlanta: Centers for Disease Control and Prevention, 2006.
17. The Maryland AIDS Administration, Department of Health and Mental Hygiene. The Maryland 2006 HIV/AIDS annual report. Available at: http://www.dhmh.state.md.us/AIDS/Data&Statistics/Statistics/ 2005AnnualReport.htm. Accessed 4 October 2007.
18. Centers for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR Recomm Rep 1998; 47:42-82.
19. Centers for Disease Control and Prevention. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. MMWR Recomm Rep 2002; 51:1-64.
20. Egger M. Outcomes of antiretroviral treatment in resource limited and industrialized countries [abstract 62]. In: 14th Conference on Retroviruses and Opportunistic Infections (Los Angeles). Alexandria, VA: Foundation for Retroviruses and Human Health, 2007:87.
21. Maryland Department of Mental Health and Hygiene. Maryland HIV statistics. 3 January 2006. Available at: http://www.dhmh.state.md.us/AIDS/ Data&Statistics/statistics.htm. Accessed 4 April 2007.
22. Garcia PM, Kalish LA, Pitt J, et al.; Women and Infants Transmission Study Group. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Engl J Med 1999; 341:394-402.
23. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000; 342:921-9.
24. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in healthcare settings. MMWR Recomm Rep 2006; 51:1-17.
25. Fincher-Mergi M, Cartone KJ, Mishler J, et al. Assessment of emergency department healthcare professional's behavior regarding HIV testing and referral for patients with STDs. AIDS Patient Care STDS 2002; 16:549-53.
26. Lyons MS, Lindsell CJ, Ledyard HK, et al. Emergency department HIV testing and counseling: an ongoing experience in a low-prevalence area. Ann Emerg Med 2005; 46:22-9.
27. Health Research and Educational Trust. Map to HIV testing laws of all US states. Chicago: American Hospital Association, 2006. Available at http://www.hret.org/hret/about/crosstate.html. Accessed 4 October 2007.